Clinical Trial Update: WIBOFA - Validation of SCT02 With ECG-App for Detection of AF [NA]

View source ↗

Summary

A completed clinical trial sponsored by Withings validates the SCT02 device with an ECG app for detecting atrial fibrillation. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Withings | Conditions: Atrial Fibrillation | NA | Status: COMPLETED